What is progressive myotonic dystrophy? Progressive myotonic dystrophy is a group of inherited muscle diseases that manifest primarily as progressively worsening muscle weakness and atrophy. It can be inherited in various ways, and some patients can be disseminated cases with no family history. Wu Shiwen, Department of Neurology, Armed Forces General Hospital Is progressive myotonic dystrophy a multiple disease? Progressive myotonic dystrophy is a group of diseases that can be divided into many kinds. The common ones are: 1, Duchenne-type myotonic dystrophy (DMD), 2, Becker-type myotonic dystrophy (BMD), 3, Emery-Dreifuss myotonic dystrophy, 4, limb-girdle myotonic dystrophy, 5, congenital myotonic dystrophy, 6, distal myotonic dystrophy; 7, facioscapulohumeral myotonic dystrophy, etc. What is the recent status of treatment of myotonic dystrophy? Among these types, DMD/BMD is the most common. Properly receiving pharmacological treatment under the guidance of a multidisciplinary clinic, combined with rehabilitation and the use of non-invasive ventilators has greatly improved the survival time and quality of life of patients, which in Europe has reached the 40s from 18 years in the past. Gene therapy may be the fundamental treatment, and more clinical studies have been conducted abroad, and we expect to enter the clinic soon. For patients with myotonic dystrophy, several issues should be noted: 1. Pay attention to respiratory and cardiac damage. 2, pay attention to rehabilitation training. 3.Pay attention to the early use of non-invasive respirator. 4.Pay attention to the child’s mental health. 5.Value the child’s opportunity to go to school and communicate with friends.